ARCHIVES

FDA Commissioner Holds Up IND While Reviewing Toxicology Guidelines

This article is from The Cancer Letter archive.

Vol. 07 No. 33 | August 14, 1981

Download PDF Visit The Full Archive

Related Articles

Senate confirms McClellan to head CMS. NCI “redeploys” $54.5 million cut from divisions to fund strategic initiatives.

March 26, 2004

Accelerated Approval Will No Longer Block Competitors, FDA Commissioner Says

June 6, 2003

Millers, Jensen, Bereblum Win $100,000 GM awards

June 6, 1980

Protocols Approved During The Month of September 2001

October 26, 2001

FDA Policy On Support Of Medical Education Near Final Form

February 5, 1993

FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials

January 27, 2012